The Clinical Value of Klotho and FGF23 in Cardiac Valve Calcification Among Patients with Chronic Kidney Disease

Yan ChenDepartment of Nephrology, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi Province, 330006, People’s Republic of ChinaCorrespondence[email protected]
View further author information

Yan-Xia ChenDepartment of Nephrology, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi Province, 330006, People’s Republic of ChinaView further author information

Chong HuangDepartment of Nephrology, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi Province, 330006, People’s Republic of ChinaView further author information

Zhi-Bing DuanDepartment of Nephrology, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi Province, 330006, People’s Republic of ChinaView further author information

Cheng-Yun XuDepartment of Nephrology, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi Province, 330006, People’s Republic of ChinaView further author information

Pages 857-866 | Published online: 15 Mar 2021

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF View EPUB EPUB

References

Bundy JD, Chen J, Yang W, et al. Risk factors for progression of coronary artery calcification in patients with chronic kidney disease: the CRIC study. Atherosclerosis. 2018;271:53–60. doi:10.1016/j.atherosclerosis.2018.02.009
PubMed Web of Science ®Google Scholar
Dong Y, Wang Z, Chen Z, et al. Comparison of visceral, body fat indices and anthropometric measures in relation to chronic kidney disease among Chinese adults from a large scale cross-sectional study. BMC Nephrol. 2018;19(1):40. doi:10.1186/s12882-018-0837-1
PubMed Web of Science ®Google Scholar
Bover J, Ureña P, Aguilar A, et al. Alkaline phosphatases in the complex chronic kidney disease-mineral and bone disorders. Calcif Tissue Int. 2018;103(6):1–14. doi:10.1007/s00223-018-0399-z
PubMed Web of Science ®Google Scholar
Tangri N, Stevens LA, Griffith J, et al. A predictive model for progression of chronic kidney disease to kidney failure. JAMA. 2011;305(15):1553–1559. doi:10.1001/jama.2011.451
PubMed Web of Science ®Google Scholar
Gansevoort RT, Correa-Rotter R, Hemmelgarn BR, et al. Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. Lancet. 2013;382(9889):339–352. doi:10.1016/S0140-6736(13)60595-4
PubMed Web of Science ®Google Scholar
Kim HJ, Kang E, Oh YK, et al. The association between soluble klotho and cardiovascular parameters in chronic kidney disease: results from the KNOW-CKD study. BMC Nephrol. 2018;19(1):51. doi:10.1186/s12882-018-0851-3
PubMed Web of Science ®Google Scholar
Lamb EJ, Levey AS, Stevens PE. The Kidney Disease Improving Global Outcomes (KDIGO) guideline update for chronic kidney disease: evolution not revolution. Clin Chem. 2013;59(3):462–465. doi:10.1373/clinchem.2012.184259
PubMed Web of Science ®Google Scholar
Oh J, Wunsch R, Turzer M, et al. Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure. Circulation. 2002;106(1):100–105. doi:10.1161/01.CIR.0000020222.63035.C0
PubMed Web of Science ®Google Scholar
Peeters MJ, van den Brand JA, van Zuilen AD, et al. Abdominal aortic calcification in patients with CKD. J Nephrol. 2017;30(1):109–118. doi:10.1007/s40620-015-0260-7
PubMed Web of Science ®Google Scholar
Haydar AA, Covic A, Colhoun H, et al. Coronary artery calcification and aortic pulse wave velocity in chronic kidney disease patients. Kidney Int. 2004;65(5):1790–1794. doi:10.1111/j.1523-1755.2004.00581.x
PubMed Web of Science ®Google Scholar
De Vinuesa SG, Ortega M, Martinez P, et al. Subclinical peripheral arterial disease in patients with chronic kidney disease: prevalence and related risk factors. Kidney Int. 2005;67(s93):S44–S47. doi:10.1111/j.1523-1755.2005.09310.x
Web of Science ®Google Scholar
Iribarren C, Sidney S, Sternfeld B, et al. Calcification of the aortic arch: risk factors and association with coronary heart disease, stroke, and peripheral vascular disease. JAMA. 2000;283(21):2810–2815. doi:10.1001/jama.283.21.2810
PubMed Web of Science ®Google Scholar
Rahman M, Xie D, Feldman HI, et al. Association between chronic kidney disease progression and cardiovascular disease: results from the CRIC Study. Am J Nephrol. 2014;40(5):399–407. doi:10.1159/000368915
PubMed Web of Science ®Google Scholar
Levitzky YS, Cupples LA, Murabito JM, et al. Prediction of intermittent claudication, ischemic stroke, and other cardiovascular disease by detection of abdominal aortic calcific deposits by plain lumbar radiographs. Am J Cardiol. 2008;101(3):326–331. doi:10.1016/j.amjcard.2007.08.032
PubMed Web of Science ®Google Scholar
Yiu KH, Graaf FRD, Velzen JEV, et al. Different value of coronary calcium score to predict obstructive coronary artery disease in patients with and without moderate chronic kidney disease. Netherlands Heart J. 2013;21(7–8):347–353. doi:10.1007/s12471-013-0409-8
PubMed Web of Science ®Google Scholar
P F S I, Daniel J, Moss SC, Goldman CK, Woods TC. Lightell. elevated serum bone morphogenetic protein 4 in patients with chronic kidney disease and coronary artery disease. J Cardiovasc Transl Res. 2013;6(2):232–238. doi:10.1007/s12265-012-9429-9
PubMed Web of Science ®Google Scholar
Andrukhova O, Slavic S, Smorodchenko A, et al. FGF23 regulates renal sodium handling and blood pressure. EMBO Mol Med. 2014;6(6):744–759. doi:10.1002/emmm.201303716
PubMed Web of Science ®Google Scholar
Nitta K. Fibroblast growth factor 23 and cardiovascular disease in patients with chronic kidney disease. Renal Replacement Therapy. 2018;4(1):1–8. doi:10.1186/s41100-018-0172-9
Google Scholar
Fukuda-Tatano S, Yamamoto H, Nakahashi O, et al. Regulation of α-klotho expression by dietary phosphate during growth periods. Calcif Tissue Int. 2019;104(6):667–678. doi:10.1007/s00223-019-00525-0
PubMed Web of Science ®Google Scholar
Navarro-González JF, Sánchez-Niño MD, Donate-Correa J, et al. Effects of pentoxifylline on soluble Klotho concentrations and renal tubular cell expression in diabetic kidney disease. Diabetes Care. 2018;41(8):1817–1820. doi:10.2337/dc18-0078
PubMed Web of Science ®Google Scholar
Mantovani A, Pernigo M, Bergamini C, et al. Heart valve calcification in patients with type 2 diabetes and nonalcoholic fatty liver disease. Metabolism. 2015;64(8):879–887. doi:10.1016/j.metabol.2015.04.003
PubMed Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

The Clinical Value of Klotho and FGF23 in Cardiac Valve Calcification Among Patients with Chronic Kidney Disease

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

The Clinical Value of Klotho and FGF23 in Cardiac Valve Calcification Among Patients with Chronic Kidney Disease

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date